# Linezolid in Healthy Volunteers

> **NCT03841721** · PHASE1 · UNKNOWN · sponsor: **Prince of Songkla University** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Linezolid oral tablet 300 mg/day for 5 day

## Key facts

- **NCT ID:** NCT03841721
- **Lead sponsor:** Prince of Songkla University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-01
- **Primary completion:** 2018-08-01
- **Final completion:** 2019-12-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03841721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03841721, "Linezolid in Healthy Volunteers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03841721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*